Sorry, we couldn't find any posts. Please try a different search.
Media
March 8, 2022
PharmaShots Interview: SalioGen Therapeutics’ Ray Tabibiazar Shares Insights on Gene Coding Platform
PharmaShots
January 5, 2022
VCs plow $115M into next-gen genetic medicine startup SalioGen, teeing up work on eye and liver diseases
FierceBiotech
January 5, 2022
Gene therapy 3.0 efforts net SalioGen a nine-figure Series B, but much remains under wraps
Endpoints News
January 5, 2022
Gene-coding startup brings in $115M, eyes expansion (Subscription Required)
Boston Business Journal
November 10, 2021
The renowned drug hunter, the Washington insider, the MIT strategist: How did one low-profile biotech enlist a dream team of top biotech advisors? (Subscription Required)
Endpoints News
March 1, 2021
Looking to take advantage of ‘silenced’ enzymes, SalioGen emerges from stealth with eyes set on gene therapy 3.0
